129 related articles for article (PubMed ID: 3871765)
1. Fluoxetine: clinical pharmacology and physiologic disposition.
Lemberger L; Bergstrom RF; Wolen RL; Farid NA; Enas GG; Aronoff GR
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):14-9. PubMed ID: 3871765
[TBL] [Abstract][Full Text] [Related]
2. Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses.
Saletu B; Grünberger J
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):45-52. PubMed ID: 3882681
[TBL] [Abstract][Full Text] [Related]
3. The human pharmacology of fluoxetine.
Lucas RA
Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S49-54. PubMed ID: 1338386
[TBL] [Abstract][Full Text] [Related]
4. The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam.
Lemberger L; Rowe H; Bosomworth JC; Tenbarge JB; Bergstrom RF
Clin Pharmacol Ther; 1988 Apr; 43(4):412-9. PubMed ID: 3128416
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of inhibiting serotonin uptake with fluoxetine in rats.
Fuller RW
Adv Biochem Psychopharmacol; 1982; 34():219-28. PubMed ID: 6753512
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interactions between lithium and fluoxetine after single and repeated fluoxetine administration in young healthy volunteers.
Breuel HP; Müller-Oerlinghausen B; Nickelsen T; Heine PR
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):415-9. PubMed ID: 7582400
[TBL] [Abstract][Full Text] [Related]
7. Absorption and excretion of a new antidepressive (SQ 10,996) in humans.
Vukovich RA; Dreyfuss J; Schreiber EC; Neiss ES
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):182-6. PubMed ID: 950260
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of tomoxetine, a potential antidepressant.
Zerbe RL; Rowe H; Enas GG; Wong D; Farid N; Lemberger L
J Pharmacol Exp Ther; 1985 Jan; 232(1):139-43. PubMed ID: 3965689
[TBL] [Abstract][Full Text] [Related]
9. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
10. Minimal interaction between fluoxetine and multiple-dose zolpidem in healthy women.
Allard S; Sainati S; Roth-Schechter B; MacIntyre J
Drug Metab Dispos; 1998 Jul; 26(7):617-22. PubMed ID: 9660843
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. Effect of ciprofloxacin on the disposition of 14C-dideoxyinosine-derived radioactivity in the rat.
Gallicano KD; Buttar HS; Moffatt JH
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):163-74. PubMed ID: 8321920
[TBL] [Abstract][Full Text] [Related]
14. The pharmacologic profile of fluoxetine.
Stark P; Fuller RW; Wong DT
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine kinetics and protein binding in normal and impaired renal function.
Aronoff GR; Bergstrom RF; Pottratz ST; Sloan RS; Wolen RL; Lemberger L
Clin Pharmacol Ther; 1984 Jul; 36(1):138-44. PubMed ID: 6610522
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration.
Farré M; Roset PN; Llorente M; Márquez M; Albet C; Pérez JA; Herrero E; Ortíz JA
Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):343-50. PubMed ID: 9379783
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats.
Martijena ID; Bustos SG; Bertotto ME; Molina VA
Eur Neuropsychopharmacol; 2005 Jan; 15(1):119-30. PubMed ID: 15572281
[TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
19. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
20. Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine.
Wong DT; Bymaster FP
Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):41-51. PubMed ID: 6974884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
